• Publications
  • Influence
Fisher's Contact Dermatitis
TLDR
This edition is revised and updated with all the new allergens patients are likely to encounter and includes patient education instructions for dealing with common allergens. Expand
Patch‐Test Results of the North American Contact Dermatitis Group 2005‐2006
TLDR
Nickel has been the most frequently positive allergen detected by the NACDG; rates significantlyincreased in the current study period and most reactions were clinically relevant. Expand
Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies.
TLDR
Ivermectin 1% cream was effective and safe in treating inflammatory lesions of papulopustular rosacea and significantly more subjects receiving IVM 1% reported having an "excellent" or "good" improvement, along with an improved QoL. Expand
North American Contact Dermatitis Group patch test results for the detection of delayed-type hypersensitivity to topical allergens.
TLDR
The usefulness of patch testing is enhanced with the number of allergens tested, because allergens not found on the commercially available screening series in the United States frequently give relevant allergic reactions. Expand
North American Contact Dermatitis Group Patch Test Results: 2015–2016
TLDR
The results confirm that the epidemic of sensitivity to methylisothiazolinone has continued in North America and that patch testing with allergens beyond a screening tray is necessary for a complete evaluation of occupational and nonoccupational ACD. Expand
North American Contact Dermatitis Group patch-test results, 1998 to 2000.
TLDR
The findings reinforce the need for a more comprehensive group of diagnostic allergens than is found in the T.R.E.U. TEST, which is sold in the United States. Expand
Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and
TLDR
Once-daily brimonidine tartrate gel 0.5% has a good safety profile and provides significantly greater efficacy relative to vehicle gel for the treatment of moderate to severe erythema of rosacea, as early as 30 minutes after application. Expand
North American Contact Dermatitis Group Patch Test Results: 2011–2012
TLDR
The NACDG patch-testing results document the beginning of the epidemic of sensitivity to methylisothiazolinones in North America, which has been well documented in Europe. Expand
Contact allergy in children referred for patch testing: North American Contact Dermatitis Group data, 2001-2004.
TLDR
Opinion is that adults and children in this group are equally likely to have allergic contact dermatitis; frequency of relevant allergen reactions differs. Expand
...
1
2
3
4
5
...